«Jurkat Cells

Below is an extended Jurkat Cells patents listing. Click here to return to the Jurkat Cells main in depth entry.

Patents :
US Patent No.	Title
7393942	Nucleic acids encoding mutant forms of Fas ligand
7407985	Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments
7410757	Method of screening disease depressant gene
7410772	Compositions and methods for treatment of non-Hodgkin's lymphoma
7410971	1,2-di(cyclic)substituted benzene compounds
7411051	Antibodies to HDPPA04 polypeptide
7411052	Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
7411076	Coumarin derivative
7413873	Method of detection and treatment of colon cancer
7414120	Compounds and methods for modulating activation of NF-.kappa.B
7417058	Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
7407784	L-amino acid oxidase with cytotoxic activity from Aplysia punctata
7407655	Method of inhibiting leukocytes with human CXC chemokine receptor 3 antibody
7405290	Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
7393944	T-bet compositions and methods of use thereof
7396468	Methods and system for protein separation
7396662	C-type lectin polypeptides
7396905	Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto
7396911	Chimeric polypeptides containing chemokine domains
7399465	Pharmaceutical compositions for treating arthritis and inflammatory disease
7399606	Methods for identifying I.kappa.B Kinase (IKK) inhibitors
7402314	In vivo activation of tumor-specific cytotoxic T cells
7402406	Methods of evaluating phosphatase inhibitors
7402435	Method of transferring a selected molecule into a cell
7417069	Halogenated triptolide derivatives as immunomodulators and anticancer agents
7417121	Human G-protein coupled receptor, HGPRBMY39
7427492	Polynucleotides encoding human tumor necrosis factor receptor-like2
7427503	Method for transferring material in a cell system
7427628	Heterocyclic compounds which inhibit leukocyte adhesion mediated by .alpha..sub.4 integrins
7427668	Antibodies binding the TNF related protein, TNF-Y
7427680	Fluorogenic substrates for BETA-lactamase gene expression
7429643	POSH nucleic acids, polypeptides and related methods
7429646	Antibodies to human tumor necrosis factor receptor-like 2
7431915	Peptides whose uptake by cells is controllable
7431924	Methods of treating inflammation using mammalian CX.sub.3C chemokine antibodies
7432084	Methods for preparing nucleic acid samples
7427471	Modified "S" antibodies
7427468	Anti-TSG101 antibodies and their uses for treatment of viral infections
7425610	Methods and materials relating to CD84-like polypeptides and polynucleotides
7419575	Microfluidic systems and methods for transport and lysis of cells and analysis of cell lysate
7419663	Treatment of complement-associated disorders
7419666	Treatment of ocular disorders
7419778	Method for high throughput cell-based assays using versatile living microarrays
7419779	Modulators of angiogenesis
7419799	Compositions and methods for the treatment of immune related diseases
7420034	HLA-A24-restricted cancer antigen peptides
7423007	Cxcr4 antagonist and use thereof
7423115	ARTS C-terminus fragments and mimetics thereof
7425554	1,2-di(cyclic)substituted benzene compounds
7432286	Pharmaceutically active sulfonyl hydrazide derivatives

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.